William Schafranek, M.D.
Cardiovascular Disease Physician · Flemington, NJ
William Schafranek, M.D. is a cardiovascular disease physician with a practice address in Flemington, New Jersey, and NPI 1982815635, issued on May 24, 2007. Check the license (New Jersey 25MA07762400, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- William Schafranek
- Credential
- M.D.
- Primary taxonomy
- Cardiovascular Disease Physician 207RC0000X
- License number
- 25MA07762400 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 1100 Wescott Dr, Flemington, NJ 08822
- Phone
- (908) 788-1710
- Enumerated
- May 24, 2007
- Entity
- Type 1 · individual
Also registered at 1100 Wescott Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Richard Arrigo, DOGastroenterology Physician1669677811
- Frederick Banerman, PA-CMedical Physician Assistant1194703140
- John Bello, MDSurgery Physician1174508725
- Joseph Bello, MDSurgery Physician1841274818
- Mamie Bowers, MDObstetrics & Gynecology Physician1124014402
- Mary Briant, MSN, FNP, CSFamily Nurse Practitioner1508902156
Verify William Schafranek in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
Search for license 25MA07762400Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
84% more Medicare Part D claims than the average cardiovascular disease physician in 2024
5,800 Medicare Part D claims for 765 beneficiaries, against an average of 3,149 among the 19,556 providers of this specialty who prescribed in Part D. Brand-name drugs were 14% of claims.
Most prescribed
- Atorvastatin Calcium789 claims
- Rosuvastatin Calcium575 claims
- Metoprolol Succinate506 claims
- Clopidogrel340 claims
- Amlodipine Besylate311 claims
- Losartan Potassium282 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's Medicare quality score for 2023: 77.7 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $1,571.73
45 payments, mostly food and beverage; the largest payer was Medtronic, Inc.. The 16,209 providers of this specialty with any payment received $4,923.81 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
2 hospital and facility affiliations
- Hunterdon Medical CenterFlemington, NJ · Acute Care Hospitals4 of 5 stars
- Hunterdon Cardiovascular AssociatesFlemington, NJ
Source: CMS Doctors and Clinicians affiliations; Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.
13 cardiovascular disease physician records list a Flemington practice address
They are 13 of the 978 NPPES records with a Flemington practice address, and 1,006 cardiovascular disease physician records in New Jersey.
All 13 in Flemington → All 1,006 in New Jersey → Every provider in Flemington →
Other cardiovascular disease physician records in New Jersey
- Kariann Abbate, MDRidgewood, NJ1548429582
- Rachel Abboud, DOPaterson, NJ1366931107
- Mary Abed, M.D.Jersey City, NJ1134185432
- Andrew Adelsheimer, MDNew Providence, NJ1881154235
- Baback Adibi, M.D.Teaneck, NJ1164491346
- Irfan AdmaniEdgewater, NJ1043228588
- Shashi Agarwal, M.D.East Orange, NJ1558416099
- Vanessa Ahearn, PA-CBelleville, NJ1962054551
- Abdullah Ahmad, MDEnglewood, NJ1760007652
- Ahsanuddin AhmadJersey City, NJ1962529388
Common questions
What is William Schafranek, M.D.'s NPI number?
William Schafranek, M.D.'s National Provider Identifier (NPI) is 1982815635, issued on May 24, 2007. An NPI identifies a provider in billing; it is not a license.
Where is William Schafranek, M.D. located?
The NPPES record lists a practice address at 1100 Wescott Dr, Flemington, NJ, 08822. Phone: (908) 788-1710. Providers update this record themselves, so call before visiting.
How can I verify William Schafranek, M.D.'s license?
NPPES lists New Jersey license number 25MA07762400, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does William Schafranek, M.D. prescribe under Medicare Part D?
In 2024, William Schafranek, M.D. had 5,800 Medicare Part D claims for 765 beneficiaries; the average among cardiovascular disease physician prescribers was 3,149. Part D covers Medicare prescriptions only.
What is William Schafranek, M.D.'s Medicare quality score?
The 2023 MIPS final score is 77.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.